Lipoxygenase inhibitor ML351 dysregulated an innate inflammatory response leading to impaired cardiac repair in acute heart failure

Bochra Tourki(University of South Florida), Ganesh V. Halade(Center for Rheumatology), Vasundhara Kain(University of Hyderabad), Laurence M. Black(Pediatric Nephrology of Alabama)
Biomedicine & Pharmacotherapy
April 15, 2021
Cited by 12


Related Papers